Objective. To examine the effect of motor activity on the magnitude and duration of altered corticomotor output following experimental muscle pain.
Introduction
When acute muscle pain is present, intracortical inhibition in the primary motor cortex (M1) is increased [1] and corticomotor output to the painful muscle is reduced [2] . These changes are thought to reflect an adaptive motor strategy that restricts movement of the painful part and protects the area from further pain, damage, or threat thereof [3] . However, a perplexing finding from previous work is that altered intracortical activity and reduced corticomotor output persist after pain has resolved [2] . These data suggest that although pain may provide a salient cue for rapid reorganization of the motor system, the removal of pain is insufficient to trigger a return to normal motor output.
The factors that trigger a return to normal motor output following the resolution of acute muscle pain are unknown. However, studies investigating motor output following an episode of acute muscle pain are usually conducted with the affected limb at rest [2] . One possibility is that resumption of normal motor activity in the postpain period is required to facilitate a return to normal motor output. Motor activity, including motor learning (e.g., five-finger sequence task) [4] , motor practice (e.g., racquet sports, violin players) [4] , skill (e.g., visuomotor tracking task), and strength training (e.g., biceps curls at one repetition max synchronized to an auditory cue) [5, 6] , and even movement observation [7] , is known to increase corticomotor output and reduce intracortical inhibition; such effects could counteract the changes observed following acute muscle pain. Evidence for a relationship between motor activity and recovery of corticomotor output can also be drawn from studies that have examined the effect of pain on motor learning. For example, when task performance is controlled (i.e., feedback is provided to ensure the same task is performed with and without pain), corticomotor output is reportedly unchanged in response to acute muscle pain and the characteristic increase in corticomotor output observed with motor learning is abolished, suggesting the two effects may cancel each other [8, 9] . Despite this, no study has examined the impact of motor activity on the magnitude and duration of reduced corticomotor output following acute muscle pain.
The present study aimed to examine the effect of motor activity undertaken immediately following the resolution of acute muscle pain on the magnitude and duration of altered corticomotor output following experimental muscle pain. It was hypothesized that motor activity would promote recovery of corticomotor output (reduced magnitude and duration of corticomotor depression) in the 30 minutes following resolution of acute muscle pain when compared with a condition where the painful limb remained at rest.
Methods

Participants
Twenty healthy, right-handed individuals volunteered to participate and were randomly allocated to either the Rest (four male, six female; 27 6 6 years, mean 6 SD) or Movement (four male, six female; 27 6 6 years) group. Participants completed a transcranial magnetic stimulation (TMS) safety screen [10] prior to commencement and had no history of musculoskeletal, neurological, or upper limb conditions. All subjects received written and verbal description of experimental procedures and provided written informed consent consistent with the Declaration of Helsinki. Experimental procedures were approved by the local human research ethics committee (N-20130055).
Experimental Protocol
In both the Rest and Movement groups, 15 motor evoked potentials (MEPs) were recorded from the right extensor carpi radialis brevis (ECRB) muscle at baseline immediately following the resolution of experimental muscle pain (prior to the movement task in this group) and at 10, 20, and 30 minutes of follow-up (Figure 1 ). In the Rest group, participants sat quietly without moving for the duration of the experiment. Particular emphasis was given to keeping the right arm completely still and relaxed at all times. Participants in the Movement group were asked to repeat a right-sided unimanual pattern of five sequential keystrokes as quickly and as accurately as possible in two three-minute blocks, with one-minute of rest between blocks [11] . Using the numbered keys from "2" to "5" on a standard keyboard, participants were asked to repeat the sequence "3-5-2-4-3" using their right hand. The sequence was provided on a computer screen placed in front of each participant. Previous studies have mapped the long finger and extensor muscles following a similar five-finger sequence task and have shown an increase in corticomotor excitability in both muscle groups [12] . The movement task was completed immediately following the resolution of experimental muscle pain and prior to recording of the 10-minute follow-up measures.
Electromyography Recordings
Electromyographic (EMG) activity was recorded from the right ECRB muscle using silver/silver chloride surface electrodes (Medicotest 720-01-K, Ambu A/S, Ballerup, Denmark) positioned over the muscle belly according to previous protocols [13] . EMG signals were sampled at 2 kHz and bandpass-filtered at 20 Hz to 1 kHz (EM006-01, SMI, Aalborg, Denmark). The EMG was further digitized by a 16-bit data acquisition card (National Instruments, NI6122) and saved by custom-made Labview software (Mr. Kick, Aalborg University).
Transcranial Magnetic Stimulation
Single-pulse TMS was delivered using a Magstim 200 stimulator (Magstim Co. LtD, Dyfed, UK) and a figure-ofeight coil. The coil was positioned over the left hemisphere at a 45 angle to the sagittal plane for each participant to preferentially induce current in a posteriorto-anterior direction. The optimal cortical site ("hotspot") to evoke responses in right ECRB, defined as the coil position that evoked a maximal peak-to-peak MEP for a given stimulation intensity, was determined and marked on the scalp. Stimulator intensity was set to evoke a peak-to-peak MEP of approximately 0.5 mV in the relaxed ECRB muscle at baseline. This intensity was kept constant throughout the experiment. Peak-to-peak MEP amplitude was measured and averaged across trials for each participant at each time point. All TMS procedures adhered to the TMS checklist for methodological quality [14] .
Experimental Muscle Pain
The site for injection of the right ECRB muscle was determined using real-time ultrasound imaging, and the skin was cleaned with alcohol. Pain was induced into the muscle by a bolus injection of 0.5 mL sterile hypertonic saline (5.8%) using a 1 mL syringe with a disposable needle (27G) [15] . Pain was recorded every 30 seconds using an 11-point numerical rating scale (NRS) anchored with "no pain" at 0 and "worst pain imaginable" at 10, immediately following injection of hypertonic saline injection until the pain returned to 0. Muscle pain was considered resolved when a participant reported a pain score of 0/10 on the NRS. To capture the characteristics and distribution of pain, the McGill pain questionnaire was administered at the end of each experiment together with pain drawings.
Data and Statistical Analyses
A two-way analysis of variance (ANOVA) was used to compare differences between the Rest vs Movement groups within baseline, immediately postpain, and at 10, 20, and 30 minutes' follow-up over time. Normality was assessed using the Shapiro-Wilk test. MEP amplitude required log transformation to meet assumptions of normality. Where appropriate, post hoc analyses were performed using Holm-Sidak multiple comparison tests. Peak pain NRS scores, pain duration, and TMS stimulator output required to evoke an MEP of approximately 0.5 mV at baseline in ECRB were compared between groups (Rest vs Movement) using t tests. Linear regression was performed to examine associations between the magnitude of the MEP depression and peak pain and duration in both groups. All data in text are presented as mean 6 standard deviation (SD). Statistical significance was set at a P value of less than 0.05.
Results
Experimental Pain Profile
Peak pain intensity (NRS scores) following injection of hypertonic saline was 7.5 61.6 in the Rest group and 6.2 6 1.7 in the Movement group (F 1.18 ¼ 3.2, P < 0.09) (Figure 2 ). The average pain duration was 8.2 6 3.6 minutes for the Rest group and 6.5 61.6 minutes for the Movement group (F 1.18 ¼ 1.7, P < 0.20) (Figure 2 ). The words most commonly used to describe pain in response to injection of hypertonic saline on the McGill pain questionnaire in both groups were cramping (75% of participants), heavy (75%), aching (70%), sharp (60%), and tiring/exhausting (40%).
Recovery of Corticomotor Excitability is not Influenced by Motor Activity
The average stimulator output required to evoke an MEP of approximately 0.5 mV peak-to-peak amplitude in right ECRB was 53.6 6 8.9 in the Rest group and 49.5 6 9.5 in the Movement group (F 1.18 ¼ 0.98, P < 0.33). MEP amplitude was reduced in both groups (effect of time F 4.72 ¼ 4.6, P < 0.002) (Figure 3 ) at 10 minutes (post hoc: P < 0.002), 20 minutes (post hoc: P < 0.02), and 30 minutes (post hoc: P < 0.037) Figure 1 Experimental protocol for the Rest (top) and Movement (bottom) groups. A one-minute rest period was applied between the two movement blocks in the Movement group. MEP ¼ motor evoked potential.
following the resolution of pain relative to baseline. MEP amplitude was not reduced immediately following pain compared with baseline (post hoc: P < 0.33). However, this was due to two individuals who showed initial facilitation at this time point in the Movement group ( Figure  4, A and B) . Excluding these subjects from the MEP analysis did not reveal a difference between the Rest and Movement groups (F 1.64 ¼ 0.23, P < 0.63). There was no difference in the magnitude of MEP depression immediately following resolution of muscle pain based on gender when the two individuals who showed large facilitatory responses (both male) were removed (male: -31 6 18%; female: mean -27 6 27%). There was no association between the magnitude of MEP depression and peak pain or pain duration in either group (Rest: peak pain r ¼ 0.068, P ¼ 0.85; duration r ¼ 0.45, P ¼ 0.19; Movement: peak pain r ¼ 0.21, P ¼ 0.56; r ¼ 0.09, P ¼ 0.81).
Discussion
Contrary to the hypothesis, performance of motor activity immediately following the resolution of acute muscle pain did not alter the magnitude or duration of corticomotor depression. These data suggest that a return to normal corticomotor output following pain 1) may depend on motor activity of a type or duration not examined here or that is delivered earlier than the postpain period (i.e., immediately before or during pain), 2) may rely on cues other than motor activity (e.g., removal of threat), or 3) is reliant on the resolution of neurophysiological mechanisms that are time dependent. Understanding corticomotor depression in the postpain period and what factors promote recovery has relevance for clinical pain where ongoing motor dysfunction, in the absence of pain, may predispose to symptom persistence or recurrence.
A recent meta-analysis demonstrates a moderate reduction in corticomotor output, measured using TMS, during acute muscle pain when motor evoked potentials (MEPs) are elicited with the target muscle at rest but not under active contraction [2] . Moreover, a strong reduction in corticomotor output in the postpain period (0-30 minutes after the resolution of pain) was demonstrated when MEPs were elicited both at rest and under active contraction [2] . Thus, corticomotor output is suppressed in the postpain period, and this effect appears to 1) persist for at least 30 minutes following pain (most studies cease recording at this time point regardless of return to normal motor output), 2) be stronger than that which is present during muscle pain, and 3) be unaffected by the amount of motor activity required to measure MEPs under active contraction. The reason for maintained suppression of corticomotor output once pain has resolved is unclear. However, it has been hypothesized that suppression persists in the postpain period as a defense against the threat of further pain and injury [3] . Importantly, it has also been hypothesized that reduced corticomotor output that persists once pain has resolved in clinical populations could lead to sustained changes in movement patterns that alter loading on surrounding tissues, decrease movement variability, and predispose to persistent or recurrent pain [3] . As a result, understanding the factors that promote a return to normal corticomotor output could have relevance in the treatment and prevention of musculoskeletal pain.
Counteracting the suppression of corticomotor output with motor activity is one strategy that could reduce the magnitude or duration of corticomotor suppression following acute muscle pain. Motor activity in a variety of forms has been repeatedly shown to increase corticomotor output in target muscles and adjacent task-related muscles [4] . Indeed, a previous study using a similar five-finger sequence task showed an increase in corticomotor excitability of the long finger flexors and extensors using TMS [12] . It is therefore surprising that motor activity immediately following the resolution of pain in the current study had no effect on the magnitude or duration of corticomotor suppression. There are several possible explanations for this lack of effect. First, it is possible that a motor intervention may need to be delivered earlier (i.e., immediately preceding or during pain) to interfere with the development of corticomotor suppression. This is supported by data from studies that examined the effect of motor learning on pain and showed no change in corticomotor output (i.e., an absence of the characteristic decrease in corticomotor output expected with pain and an absence of the characteristic increase expected with motor learning, suggesting effects are cancelled out) when the task was performed during pain [8, 9] . Similarly, a particular type of motor activity (e.g., motor learning, motor control, strength) specifically targeted to the painful muscle may be required. Future studies should explore the optimal timeframe and type of motor intervention that best promotes a return to normal corticomotor output following pain. This information is important given that general advice to stay active is provided in most clinical guidelines for the management of acute clinical pain, yet it is unknown what type, how much, or precisely when motor activity should be adopted to improve clinical outcomes.
A second explanation for our findings is that motor activity does not provide a sufficient trigger for return to normal corticomotor output. It is possible that other factors, such as removal of threat, the stress response, or psychosocial determinants, are more important in driving the return to normal output. Indeed, these factors are known to correlate with recovery of function in some people with clinical musculoskeletal pain [16] [17] [18] . However, this possibility has yet to be explored in response to acute muscle pain.
Finally, it is plausible that recovery of corticomotor output following acute muscle pain is related to timedependent neurophysiological mechanisms. For example, it has recently been shown that circuits involved in sensorimotor integration (short-and long-latency afferent inhibition) exhibit less inhibition in response to acute muscle pain, but only once pain has resolved [19] . These mechanisms are hypothesized to contribute to recovery of corticomotor output following pain. Eventual recovery may reflect a balance between the mechanisms involved in recovery [19] and those involved in generating a protective motor strategy (reduced corticomotor output) [1] , causing corticomotor suppression to persist early after the resolution of pain. If this is the case, interventions that enhance the excitability of networks involved in sensorimotor integration may be more effective at promoting recovery following acute muscle pain.
This study has several limitations. First, data was collected on a relatively small sample. Although it is possible that our sample was underpowered to detect an effect between groups, the data showed no evidence of a trend for an effect of group on corticomotor output over time (P < 0.97). Second, a vehicle control was not included. Vehicle controls are commonly used in experimental pain studies and rarely, if ever, show an effect [20, 21] . For example, previous studies of similar methodology have demonstrated no effect of intramuscular isotonic saline solution on the amplitude or latency of MEPs from upper limb muscles [22, 23] . Further, corticomotor output has been shown to be stable during 30 minutes of controlled, quiet sitting [24] and is reliable over short (0-4 days) and long (0-14 days, 0-1 months) intervals [25, 26] . Taken together, these findings indicate that the measures used in this study to evaluate corticomotor output are not sensitive to time effects. Thus, our findings are unlikely to be replicated in a no-pain control condition. Finally, it is unknown how these findings may translate to other forms of pain such as acute inflammatory or cutaneous pain or in individuals who experience an acute exacerbation of a chronic musculoskeletal pain condition. Future studies should seek to examine corticomotor excitability and motor activity in these pain populations.
Conclusion
This pilot study is the first to examine the effect of a motor task performed immediately following the resolution of acute muscle pain on the magnitude and duration of corticomotor suppression. These data suggest that this intervention does not affect corticomotor output in the 30 minutes following resolution of acute muscle pain. Future studies should seek to determine whether different motor interventions applied at different stages of pain (i.e., immediately before or during) or other external triggers are more effective at promoting recovery of corticomotor output following pain. Such data may have relevance for the treatment and prevention of clinical pain syndromes where persistence of altered corticomotor output could underpin persistence and recurrence of pain.
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